XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities    
Net income (loss) $ 74,491 $ (7,149)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Stock-based compensation 33,495 22,642
(Gain) loss in fair value of warrant liability (9,905) 45,579
Amortization of debt discount and issuance costs 675 683
Depreciation and amortization 7,807 12,595
Provision for expected credit losses (24) (642)
Deferred income taxes 0 (1,243)
Non-cash lease expense 2,189 1,237
Changes in operating assets and liabilities:    
Accounts receivable (9,198) (9,436)
Prepaid expenses and deferred charges (4,110) (1,136)
Other current assets 187 1,808
Other assets (275) (191)
Accounts payable 793 (1,660)
Accrued expenses and other current liabilities 19,666 3,619
Deferred revenue 3,502 714
Lease liability (2,366) (2,008)
Other liabilities (167) 12
Net cash provided by operating activities 116,760 65,424
Investing activities    
Purchase of property and equipment (524) (699)
Additions to capitalized software development costs (5,190) (3,388)
Net cash used in investing activities (5,714) (4,087)
Financing activities    
Proceeds from the exercise of stock options 1,533 2,031
Withholding taxes paid on stock-based compensation (17,714) (5,592)
Repurchases of common stock under the stock repurchase program (450,506) 0
Proceeds from the exercise of warrants 314,124 1
Payment for the redemption of warrants (58) 0
Principal payments on debt (11,250) (47,050)
Net cash used in financing activities (163,871) (50,610)
Net (decrease) increase in cash, cash equivalents and restricted cash (52,825) 10,727
Cash, cash equivalents and restricted cash, beginning of the period 59,757 28,998
Cash, cash equivalents and restricted cash, end of the period 6,932 39,725
Reconciliation of cash, cash equivalents and restricted cash    
Cash and cash equivalents 6,327 39,120
Restricted cash 605 605
Cash, cash equivalents and restricted cash 6,932 39,725
Supplemental disclosure of cash flow information:    
Cash interest paid 12,274 20,291
Income taxes paid 904 9,959
Supplemental disclosure of non-cash investing activities:    
Capitalized software development costs accrued but not paid 973 292
Supplemental disclosure of non-cash financing activities:    
Repurchase of common stock for net settlement of equity awards 795 51
Issuance of common stock for the settlement of KPI Awards 3,609 2,350
Issuance of common stock for the settlement of certain market condition liability-classified awards 9,163 0
Issuance of common stock for the cashless exercise of warrants 63,029 0
Issuance of common stock for the exercise of warrants $ 179,186 $ 0